- David Breen
AdventHealth is joining a collaboration with Quanterix Corporation and other leading health systems with the goal to improve and simplify Alzheimer’s disease diagnosis. These relationships further the company’s goal to build the global infrastructure necessary for Alzheimer’s testing by expanding clinical access to Quanterix’s leading blood biomarker tests.
In addition to AdventHealth, Mass General Brigham, the Mayo Clinic, the Medical University of South Carolina and UPMC will leverage Quanterix technology and tests to streamline care for Alzheimer’s patients. Quanterix is a Massachusetts-based company specializing in biomarker detection.
Blood-based biomarker testing offers Alzheimer’s patients a non-invasive method and greater access to testing overall. Traditionally, diagnosis has relied on a combination of symptom presentation, brain imaging, and the detection of biomarkers in the cerebrospinal fluid. This approach is not only burdensome and invasive for patients, but also costly, making them unsuitable for most primary and secondary care settings. This inaccessibility has left 50-70% of symptomatic Alzheimer’s patients without a correct and timely diagnosis.
“New resources available to aid in diagnosis and treatment of Alzheimer’s disease have contributed to a more optimistic environment for AD patient care,” said Kirk Erickson, PhD, director of translational neuroscience at the AdventHealth Neuroscience Institute. “With simplified, affordable, non-invasive testing methods, physicians can proactively evaluate and monitor patients with memory concerns. The availability of blood-based biomarker testing to the AdventHealth network has the potential to help a wide population concerned about mild cognitive impairment and aid physicians in their diagnosis.”
Read more here.
Recent News
Across AdventHealth, a community of team members unites under a shared mission, serving more than 8 million patients annually.
Health officials said Monday that a Louisiana patient who had been hospitalized with H5N1 died, marking the first U.S. death from bird flu.
AdventHealth completed the acquisition of a western North Carolina hospital days after Hurricane Helene hammered the region. Leaders talk about wrapping up the deal in a crisis and helping a...
AdventHealth Well 65+ aims to provide highly personalized care to patients who are age 65 or older.
AdventHealth has named Andrew Santos president/CEO of AdventHealth North Pinellas, effective Jan. 12.
David Weis has been promoted to serve as president/CEO for the region covering east Volusia, Flagler and St. Johns counties. Lorenzo Brown has been promoted to serve as president/CEO for the region...
On the newest Inspiring Wholeness podcast, Obie Diaz, local morning radio show host, shares how a routine physical eventually led to two open heart surgeries.
St. Luke's Hospital in Columbus, North Carolina, had been planning to ink a management agreement with AdventHealth, one of the nation's largest health systems, for months. But just days before the...
AdventHealth President and CEO Terry Shaw has been named one of Modern Healthcare’s 100 Most Influential People in Healthcare for 2024, marking continued recognition of Shaw as a transformative leader...
AdventHealth has named Elise MacCarroll-Wright as president and CEO of UChicago Medicine AdventHealth Hinsdale in its Great Lakes Region, effective Jan. 6, 2025.
AdventHealth has named Dave Tkachuck president/CEO for UChicago Medicine AdventHealth La Grange, effective Jan. 6.
AdventHealth leaders faced an unexpected decision: Move forward with a planned acquisition St. Luke's Hospital or delay the deal until after Hurricane Helene passed.